Biotech News

MIMEDX to Host First Quarter 2026 Operating and Financial Results Conference Call on April 29

MiMedx (MDXG)MiMedx2026-04-22 12:00 ESTEarnings

MARIETTA, Ga., April 22, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the first quarter ended March 31, 2026 after the market close on Wednesday, April 29, 2026.

Related news

MDXGMiMedx2026-07-20 12:00 EST

MIMEDX to Host Second Quarter 2026 Operating and Financial Results Conference Call on July 29

MDXGMiMedx2026-02-17 13:00 EST

MIMEDX to Host Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call on February 25

CHRSCoherus BioSciences, Inc.2026-05-11 20:05 EST

Coherus Oncology Reports First Quarter 2026 Financial Results and Provides Business Update

ENTXEntera Bio2026-05-08 20:05 EST

Entera Announces First Quarter 2026 Financial Results and Updates Across its Oral Peptide Programs

STTKShattuck Labs2026-05-07 10:15 EST

Shattuck Labs Reports First Quarter 2026 Financial Results and Recent Business Highlights

RXRXRecursion2026-04-29 11:59 EST

Recursion to Report First Quarter 2026 Business Updates and Financial Results on May 6

ENTXEntera Bio2025-05-09 20:05 EST

Entera Bio Announces First Quarter 2025 Financial Results and Business Updates

STTKShattuck Labs2025-05-01 20:20 EST

Shattuck Labs Reports First Quarter 2025 Financial Results and Recent Business Highlights

RXRXRecursion2026-08-05 10:30 EST

Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program

APGEApogee Therapeutics2026-05-11 11:00 EST

Apogee Therapeutics Provides Pipeline Progress and Reports First Quarter 2026 Financial Results

View all latest news

MiMedx

Placental Tissue Products MIMEDX develops and commercializes placental-tissue products for wound care, burns and surgery. Its processing and product portfolio are designed to provide extracellular-matrix and biologic materials that support healing and tissue repair. Wound-Care Portfolio The company has more than a decade of experience...

Recent company news

MDXGMiMedx2026-07-29 20:07 EST

MIMEDX Announces Second Quarter 2026 Operating & Financial Results

MDXGMiMedx2026-07-29 20:01 EST

MIMEDX to Acquire Sanara MedTech

MDXGMiMedx2026-07-20 12:00 EST

MIMEDX to Host Second Quarter 2026 Operating and Financial Results Conference Call on July 29

MDXGMiMedx2026-05-21 12:45 EST

MIMEDX to Participate in Craig-Hallum 23rd Annual Institutional Investor Conference

MDXGMiMedx2026-05-08 12:00 EST

MIMEDX Announces Launch of G4Derm® Plus

Stock data

Close: 4.18 USD
Market cap: 531.74M USD
Exchange: NASDAQ
Sector: Biopharma
Location: United States